1 Study Coverage 1.1 DTaP Vaccine Product Introduction 1.2 Market by Type 1.2.1 Global DTaP Vaccine Market Size Growth Rate by Type 1.2.2 Inactivated Vaccine 1.2.3 Live Attenuated Vaccine 1.3 Market by Application 1.3.1 Global DTaP Vaccine Market Size Growth Rate by Application 1.3.2 Government Institution 1.3.3 Private Sector 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global DTaP Vaccine Market Size, Estimates and Forecasts 2.1.1 Global DTaP Vaccine Revenue 2016-2027 2.1.2 Global DTaP Vaccine Sales 2016-2027 2.2 Global DTaP Vaccine, Market Size by Region: 2016 VS 2021 VS 2027 2.3 DTaP Vaccine Historical Market Size by Region (2016-2021) 2.3.1 Global DTaP Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global DTaP Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 DTaP Vaccine Market Estimates and Projections by Region (2022-2027) 2.4.1 Global DTaP Vaccine Sales Forecast by Region (2022-2027) 2.4.2 Global DTaP Vaccine Revenue Forecast by Region (2022-2027) 3 Global DTaP Vaccine Competitor Landscape by Players 3.1 Global Top DTaP Vaccine Manufacturers by Sales 3.1.1 Global DTaP Vaccine Sales by Manufacturer (2016-2021) 3.1.2 Global DTaP Vaccine Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top DTaP Vaccine Manufacturers by Revenue 3.2.1 Key DTaP Vaccine Manufacturers Covered: Ranking by Revenue 3.2.2 Global DTaP Vaccine Revenue by Manufacturers (2016-2021) 3.2.3 Global DTaP Vaccine Revenue Share by Manufacturers (2016-2021) 3.2.4 Global DTaP Vaccine Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by DTaP Vaccine Revenue in 2020 3.2.6 Global DTaP Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global DTaP Vaccine Price by Manufacturers 3.4 Global DTaP Vaccine Manufacturing Base Distribution, Product Types 3.4.1 DTaP Vaccine Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers DTaP Vaccine Product Type 3.4.3 Date of International Manufacturers Enter into DTaP Vaccine Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global DTaP Vaccine Market Size by Type (2016-2021) 4.1.1 Global DTaP Vaccine Sales by Type (2016-2021) 4.1.2 Global DTaP Vaccine Revenue by Type (2016-2021) 4.1.3 DTaP Vaccine Average Selling Price (ASP) by Type (2016-2021) 4.2 Global DTaP Vaccine Market Size Forecast by Type (2022-2027) 4.2.1 Global DTaP Vaccine Sales Forecast by Type (2022-2027) 4.2.2 Global DTaP Vaccine Revenue Forecast by Type (2022-2027) 4.2.3 DTaP Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global DTaP Vaccine Market Size by Application (2016-2021) 5.1.1 Global DTaP Vaccine Sales by Application (2016-2021) 5.1.2 Global DTaP Vaccine Revenue by Application (2016-2021) 5.1.3 DTaP Vaccine Price by Application (2016-2021) 5.2 DTaP Vaccine Market Size Forecast by Application (2022-2027) 5.2.1 Global DTaP Vaccine Sales Forecast by Application (2022-2027) 5.2.2 Global DTaP Vaccine Revenue Forecast by Application (2022-2027) 5.2.3 Global DTaP Vaccine Price Forecast by Application (2022-2027) 6 China by Players, Type and Application 6.1 China DTaP Vaccine Market Size YoY Growth 2016-2027 6.1.1 China DTaP Vaccine Sales YoY Growth 2016-2027 6.1.2 China DTaP Vaccine Revenue YoY Growth 2016-2027 6.1.3 China DTaP Vaccine Market Share in Global Market 2016-2027 6.2 China DTaP Vaccine Market Size by Players (International and Local Players) 6.2.1 China Top DTaP Vaccine Players by Sales (2016-2021) 6.2.2 China Top DTaP Vaccine Players by Revenue (2016-2021) 6.3 China DTaP Vaccine Historic Market Review by Type (2016-2021) 6.3.1 China DTaP Vaccine Sales Market Share by Type (2016-2021) 6.3.2 China DTaP Vaccine Revenue Market Share by Type (2016-2021) 6.3.3 China DTaP Vaccine Price by Type (2016-2021) 6.4 China DTaP Vaccine Market Estimates and Forecasts by Type (2022-2027) 6.4.1 China DTaP Vaccine Sales Forecast by Type (2022-2027) 6.4.2 China DTaP Vaccine Revenue Forecast by Type (2022-2027) 6.4.3 China DTaP Vaccine Price Forecast by Type (2022-2027) 6.5 China DTaP Vaccine Historic Market Review by Application (2016-2021) 6.5.1 China DTaP Vaccine Sales Market Share by Application (2016-2021) 6.5.2 China DTaP Vaccine Revenue Market Share by Application (2016-2021) 6.5.3 China DTaP Vaccine Price by Application (2016-2021) 6.6 China DTaP Vaccine Market Estimates and Forecasts by Application (2022-2027) 6.6.1 China DTaP Vaccine Sales Forecast by Application (2022-2027) 6.6.2 China DTaP Vaccine Revenue Forecast by Application (2022-2027) 6.6.3 China DTaP Vaccine Price Forecast by Application (2022-2027) 7 North America 7.1 North America DTaP Vaccine Market Size YoY Growth 2016-2027 7.2 North America DTaP Vaccine Market Facts & Figures by Country 7.2.1 North America DTaP Vaccine Sales by Country (2016-2021) 7.2.2 North America DTaP Vaccine Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific DTaP Vaccine Market Size YoY Growth 2016-2027 8.2 Asia Pacific DTaP Vaccine Market Facts & Figures by Region 8.2.1 Asia Pacific DTaP Vaccine Sales by Region (2016-2021) 8.2.2 Asia Pacific DTaP Vaccine Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe DTaP Vaccine Market Size YoY Growth 2016-2027 9.2 Europe DTaP Vaccine Market Facts & Figures by Country 9.2.1 Europe DTaP Vaccine Sales by Country (2016-2021) 9.2.2 Europe DTaP Vaccine Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America DTaP Vaccine Market Size YoY Growth 2016-2027 10.2 Latin America DTaP Vaccine Market Facts & Figures by Country 10.2.1 Latin America DTaP Vaccine Sales by Country (2016-2021) 10.2.2 Latin America DTaP Vaccine Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa DTaP Vaccine Market Size YoY Growth 2016-2027 11.2 Middle East and Africa DTaP Vaccine Market Facts & Figures by Country 11.2.1 Middle East and Africa DTaP Vaccine Sales by Country (2016-2021) 11.2.2 Middle East and Africa DTaP Vaccine Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 GlaxoSmithKline 12.1.1 GlaxoSmithKline Corporation Information 12.1.2 GlaxoSmithKline Description and Business Overview 12.1.3 GlaxoSmithKline DTaP Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.1.4 GlaxoSmithKline DTaP Vaccine Products Offered 12.1.5 GlaxoSmithKline Recent Development 12.2 Sanofi Pasteur, Ltd. 12.2.1 Sanofi Pasteur, Ltd. Corporation Information 12.2.2 Sanofi Pasteur, Ltd. Description and Business Overview 12.2.3 Sanofi Pasteur, Ltd. DTaP Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Sanofi Pasteur, Ltd. DTaP Vaccine Products Offered 12.2.5 Sanofi Pasteur, Ltd. Recent Development 12.3 Merck 12.3.1 Merck Corporation Information 12.3.2 Merck Description and Business Overview 12.3.3 Merck DTaP Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Merck DTaP Vaccine Products Offered 12.3.5 Merck Recent Development 12.11 GlaxoSmithKline 12.11.1 GlaxoSmithKline Corporation Information 12.11.2 GlaxoSmithKline Description and Business Overview 12.11.3 GlaxoSmithKline DTaP Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.11.4 GlaxoSmithKline DTaP Vaccine Products Offered 12.11.5 GlaxoSmithKline Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 DTaP Vaccine Industry Trends 13.2 DTaP Vaccine Market Drivers 13.3 DTaP Vaccine Market Challenges 13.4 DTaP Vaccine Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 DTaP Vaccine Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global DTaP Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Inactivated Vaccine Table 3. Major Manufacturers of Live Attenuated Vaccine Table 4. Global DTaP Vaccine Market Size Growth Rate by Application (2021-2027) & (K Doses) Table 5. Global DTaP Vaccine Market Size by Region (K Doses) & (US$ Million), 2016 VS 2021 VS 2027 Table 6. Global DTaP Vaccine Sales by Regions (2016-2021) & (K Doses) Table 7. Global DTaP Vaccine Sales Market Share by Regions (2016-2021) Table 8. Global DTaP Vaccine Revenue by Regions (2016-2021) & (US$ Million) Table 9. Global DTaP Vaccine Sales Forecast by Region (2022-2027) & (K Doses) Table 10. Global DTaP Vaccine Sales Market Share Forecast by Region (2022-2027) Table 11. Global DTaP Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million) Table 12. Global DTaP Vaccine Revenue Market Share Forecast by Region (2022-2027) Table 13. Global DTaP Vaccine Sales by Manufacturers (2016-2021) (K Doses) Table 14. Global DTaP Vaccine Sales Share by Manufacturers (2016-2021) Table 15. Ranking of Global Top DTaP Vaccine Manufacturers by Revenue (US$ Million) in 2020 Table 16. DTaP Vaccine Revenue by Manufacturers (2016-2021) (US$ Million) Table 17. DTaP Vaccine Revenue Share by Manufacturers (2016-2021) Table 18. Global DTaP Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 19. Global DTaP Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in DTaP Vaccine as of 2020) Table 20. Key Manufacturers DTaP Vaccine Price (2016-2021) (US$/Dose) Table 21. DTaP Vaccine Manufacturers Manufacturing Base Distribution and Headquarters Table 22. Manufacturers DTaP Vaccine Product Type Table 23. Date of International Manufacturers Enter into DTaP Vaccine Market Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans Table 25. Global DTaP Vaccine Sales by Type (2016-2021) (K Doses) Table 26. Global DTaP Vaccine Sales Share by Type (2016-2021) Table 27. Global DTaP Vaccine Revenue by Type (2016-2021) (US$ Million) Table 28. Global DTaP Vaccine Revenue Share by Type (2016-2021) Table 29. DTaP Vaccine Average Selling Price (ASP) by Type (2016-2021) & (US$/Dose) Table 30. Global DTaP Vaccine Sales Forecast by Type (2022-2027) & (K Doses) Table 31. Global DTaP Vaccine Sales Market Share Forecast by Type (2022-2027) Table 32. Global DTaP Vaccine Revenue Forecast V (2022-2027) & (US$ Million) Table 33. Global DTaP Vaccine Revenue Market Share Forecast by Type (2022-2027) Table 34. Global DTaP Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Dose) Table 35. Global DTaP Vaccine Sales by Application (2016-2021) (K Doses) Table 36. Global DTaP Vaccine Sales Share by Application (2016-2021) Table 37. Global DTaP Vaccine Revenue by Application (2016-2021) (US$ Million) Table 38. Global DTaP Vaccine Revenue Share by Application (2016-2021) Table 39. DTaP Vaccine Average Selling Price (ASP) by Application (2016-2021) & (US$/Dose) Table 40. Global DTaP Vaccine Sales Forecast by Application (2022-2027) & (K Doses) Table 41. Global DTaP Vaccine Sales Market Share Forecast by Application (2022-2027) Table 42. Global DTaP Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million) Table 43. Global DTaP Vaccine Revenue Market Share Forecast by Application (2022-2027) Table 44. Global DTaP Vaccine Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Dose) Table 45. China DTaP Vaccine Sales (K Doses) of Key Companies (2016-2021) Table 46. China DTaP Vaccine Sales Share by Company (2016-2021) Table 47. China DTaP Vaccine Revenue (US$ Million) by Company (2016-2021) Table 48. China DTaP Vaccine Revenue Share by Company (2016-2021) Table 49. China DTaP Vaccine Sales (K Doses) by Type (2016-2021) Table 50. China DTaP Vaccine Sales Share by Type (2016-2021) Table 51. China DTaP Vaccine Revenue (US$ Million) Market Share by Type (2016-2021) Table 52. China DTaP Vaccine Price (US$/Dose) by Type (2016-2021) Table 53. China DTaP Vaccine Sales (K Doses) by Type (2022-2027) Table 54. China DTaP Vaccine Sales Share by Type (2022-2027) Table 55. China DTaP Vaccine Revenue (US$ Million) Market Share by Type (2022-2027) Table 56. China DTaP Vaccine Revenue Share by Type (2022-2027) Table 57. China DTaP Vaccine Price (US$/Dose) by Type (2022-2027) Table 58. China DTaP Vaccine Sales (K Doses) by Application (2016-2021) Table 59. China DTaP Vaccine Sales Share by Application (2016-2021) Table 60. China DTaP Vaccine Revenue (US$ Million) Market Share by Application (2016-2021) Table 61. China DTaP Vaccine Price (US$/Dose) by Application (2016-2021) Table 62. China DTaP Vaccine Sales (K Doses) by Application (2022-2027) Table 63. China DTaP Vaccine Sales Share by Application (2022-2027) Table 64. China DTaP Vaccine Revenue (US$ Million) Market Share by Application (2022-2027) Table 65. China DTaP Vaccine Revenue Share by Application (2022-2027) Table 66. China DTaP Vaccine Price (US$/Dose) by Application (2022-2027) Table 67. North America DTaP Vaccine Sales by Country (2016-2021) & (K Doses) Table 68. North America DTaP Vaccine Sales Market Share by Country (2016-2021) Table 69. North America DTaP Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 70. North America DTaP Vaccine Revenue Market Share by Country (2016-2021) Table 71. Asia Pacific DTaP Vaccine Sales by Region (2016-2021) & (K Doses) Table 72. Asia Pacific DTaP Vaccine Sales Market Share by Region (2016-2021) Table 73. Asia Pacific DTaP Vaccine Revenue by Region (2016-2021) & (US$ Million) Table 74. Asia Pacific DTaP Vaccine Revenue Market Share by Region (2016-2021) Table 75. Europe DTaP Vaccine Sales by Country (2016-2021) & (K Doses) Table 76. Europe DTaP Vaccine Sales Market Share by Country (2016-2021) Table 77. Europe DTaP Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 78. Europe DTaP Vaccine Revenue Market Share by Country (2016-2021) Table 79. Latin America DTaP Vaccine Sales by Country (2016-2021) & (K Doses) Table 80. Latin America DTaP Vaccine Sales Market Share by Country (2016-2021) Table 81. Latin Americaa DTaP Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 82. Latin America DTaP Vaccine Revenue Market Share by Country (2016-2021) Table 83. Middle East and Africa DTaP Vaccine Sales by Country (2016-2021) & (K Doses) Table 84. Middle East and Africa DTaP Vaccine Sales Market Share by Country (2016-2021) Table 85. Middle East and Africa DTaP Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 86. Middle East and Africa DTaP Vaccine Revenue Market Share by Country (2016-2021) Table 87. GlaxoSmithKline Corporation Information Table 88. GlaxoSmithKline Description and Business Overview Table 89. GlaxoSmithKline DTaP Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 90. GlaxoSmithKline DTaP Vaccine Product Table 91. GlaxoSmithKline Recent Development Table 92. Sanofi Pasteur, Ltd. Corporation Information Table 93. Sanofi Pasteur, Ltd. Description and Business Overview Table 94. Sanofi Pasteur, Ltd. DTaP Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 95. Sanofi Pasteur, Ltd. Product Table 96. Sanofi Pasteur, Ltd. Recent Development Table 97. Merck Corporation Information Table 98. Merck Description and Business Overview Table 99. Merck DTaP Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 100. Merck Product Table 101. Merck Recent Development Table 102. DTaP Vaccine Market Trends Table 103. DTaP Vaccine Market Drivers Table 104. DTaP Vaccine Market Challenges Table 105. DTaP Vaccine Market Restraints Table 106. DTaP Vaccine Customers List Table 107. DTaP Vaccine Distributors List Table 108. Research Programs/Design for This Report Table 109. Key Data Information from Secondary Sources Table 110. Key Data Information from Primary Sources List of Figures Figure 1. DTaP Vaccine Product Picture Figure 2. Global DTaP Vaccine Sales Market Share by Type in 2020 & 2027 Figure 3. Inactivated Vaccine Product Picture Figure 4. Live Attenuated Vaccine Product Picture Figure 5. Global DTaP Vaccine Sales Market Share by Application in 2020 & 2027 Figure 6. Government Institution Figure 7. Private Sector Figure 8. Other Figure 9. DTaP Vaccine Report Years Considered Figure 10. Global DTaP Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global DTaP Vaccine Market Size 2016-2027 (US$ Million) Figure 12. Global DTaP Vaccine Sales 2016-2027 (K Doses) Figure 13. Global DTaP Vaccine Market Size Market Share by Region: 2021 Versus 2027 Figure 14. Global DTaP Vaccine Sales Market Share by Region (2016-2021) Figure 15. Global DTaP Vaccine Sales Market Share by Region in 2020 Figure 16. Global DTaP Vaccine Revenue Market Share by Region (2016-2021) Figure 17. Global DTaP Vaccine Revenue Market Share by Region in 2020 Figure 18. Global DTaP Vaccine Sales Share by Manufacturer in 2020 Figure 19. The Top 10 and 5 Players Market Share by DTaP Vaccine Revenue in 2020 Figure 20. DTaP Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 21. Global DTaP Vaccine Sales Market Share by Type (2016-2021) Figure 22. Global DTaP Vaccine Sales Market Share by Type in 2020 Figure 23. Global DTaP Vaccine Revenue Market Share by Type (2016-2021) Figure 24. Global DTaP Vaccine Revenue Market Share by Type in 2020 Figure 25. Global DTaP Vaccine Sales Market Share by Application (2016-2021) Figure 26. Global DTaP Vaccine Sales Market Share by Application in 2020 Figure 27. Global DTaP Vaccine Revenue Market Share by Application (2016-2021) Figure 28. Global DTaP Vaccine Revenue Market Share by Application in 2020 Figure 29. China DTaP Vaccine Sales Growth Rate 2016-2027 (K Doses) Figure 30. China DTaP Vaccine Revenue Growth Rate 2016-2027 (US$ Million) Figure 31. China DTaP Vaccine Market Share in Global Market 2016-2027 Figure 32. China 5 and 10 Largest DTaP Vaccine Players Market Share by Revenue in DTaP Vaccine in 2020 Figure 33. China DTaP Vaccine Revenue Share by Type (2016-2021) Figure 34. China DTaP Vaccine Revenue Growth Rate by Type in 2016 & 2020 Figure 35. China DTaP Vaccine Revenue Share by Application (2016-2021) Figure 36. China DTaP Vaccine Revenue Growth Rate by Application in 2016 & 2020 Figure 37. North America DTaP Vaccine Sales Growth Rate 2016-2021 (K Doses) Figure 38. North America DTaP Vaccine Revenue Growth Rate 2016-2021 (US$ Million) Figure 39. North America DTaP Vaccine Sales Market Share by Country in 2020 Figure 40. North America DTaP Vaccine Revenue Market Share by Country in 2020 Figure 41. U.S. DTaP Vaccine Sales Growth Rate (2016-2021) (K Doses) Figure 42. U.S. DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Canada DTaP Vaccine Sales Growth Rate (2016-2021) (K Doses) Figure 44. Canada DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Europe DTaP Vaccine Sales Growth Rate 2016-2021 (K Doses) Figure 46. Europe DTaP Vaccine Revenue Growth Rate 2016-2021 (US$ Million) Figure 47. Europe DTaP Vaccine Sales Market Share by Country in 2020 Figure 48. Europe DTaP Vaccine Revenue Market Share by Country in 2020 Figure 49. Germany DTaP Vaccine Sales Growth Rate (2016-2021) (K Doses) Figure 50. Germany DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 51. France DTaP Vaccine Sales Growth Rate (2016-2021) (K Doses) Figure 52. France DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. U.K. DTaP Vaccine Sales Growth Rate (2016-2021) (K Doses) Figure 54. U.K. DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. Italy DTaP Vaccine Sales Growth Rate (2016-2021) (K Doses) Figure 56. Italy DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. Russia DTaP Vaccine Sales Growth Rate (2016-2021) (K Doses) Figure 58. Russia DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Asia Pacific DTaP Vaccine Sales Growth Rate 2016-2021 (K Doses) Figure 60. Asia Pacific DTaP Vaccine Revenue Growth Rate 2016-2021 (US$ Million) Figure 61. Asia Pacific DTaP Vaccine Sales Market Share by Region in 2020 Figure 62. Asia Pacific DTaP Vaccine Revenue Market Share by Region in 2020 Figure 63. China DTaP Vaccine Sales Growth Rate (2016-2021) (K Doses) Figure 64. China DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 65. Japan DTaP Vaccine Sales Growth Rate (2016-2021) (K Doses) Figure 66. Japan DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 67. South Korea DTaP Vaccine Sales Growth Rate (2016-2021) (K Doses) Figure 68. South Korea DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. India DTaP Vaccine Sales Growth Rate (2016-2021) (K Doses) Figure 70. India DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. Australia DTaP Vaccine Sales Growth Rate (2016-2021) (K Doses) Figure 72. Australia DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. Taiwan DTaP Vaccine Sales Growth Rate (2016-2021) (K Doses) Figure 74. Taiwan DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. Indonesia DTaP Vaccine Sales Growth Rate (2016-2021) (K Doses) Figure 76. Indonesia DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Thailand DTaP Vaccine Sales Growth Rate (2016-2021) (K Doses) Figure 78. Thailand DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Malaysia DTaP Vaccine Sales Growth Rate (2016-2021) (K Doses) Figure 80. Malaysia DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Philippines DTaP Vaccine Sales Growth Rate (2016-2021) (K Doses) Figure 82. Philippines DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Vietnam DTaP Vaccine Sales Growth Rate (2016-2021) (K Doses) Figure 84. Vietnam DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Latin America DTaP Vaccine Sales Growth Rate 2016-2021 (K Doses) Figure 86. Latin America DTaP Vaccine Revenue Growth Rate 2016-2021 (US$ Million) Figure 87. Latin America DTaP Vaccine Sales Market Share by Country in 2020 Figure 88. Latin America DTaP Vaccine Revenue Market Share by Country in 2020 Figure 89. Mexico DTaP Vaccine Sales Growth Rate (2016-2021) (K Doses) Figure 90. Mexico DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 91. Brazil DTaP Vaccine Sales Growth Rate (2016-2021) (K Doses) Figure 92. Brazil DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 93. Argentina DTaP Vaccine Sales Growth Rate (2016-2021) (K Doses) Figure 94. Argentina DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 95. Middle East and Africa DTaP Vaccine Sales Growth Rate 2016-2021 (K Doses) Figure 96. Middle East and Africa DTaP Vaccine Revenue Growth Rate 2016-2021 (US$ Million) Figure 97. Middle East and Africa DTaP Vaccine Sales Market Share by Country in 2020 Figure 98. Middle East and Africa DTaP Vaccine Revenue Market Share by Country in 2020 Figure 99. Turkey DTaP Vaccine Sales Growth Rate (2016-2021) (K Doses) Figure 100. Turkey DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 101. Saudi Arabia DTaP Vaccine Sales Growth Rate (2016-2021) (K Doses) Figure 102. Saudi Arabia DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 103. UAE DTaP Vaccine Sales Growth Rate (2016-2021) (K Doses) Figure 104. UAE DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 105. DTaP Vaccine Value Chain Figure 106. Channels of Distribution Figure 107. Distributors Profiles Figure 108. Bottom-up and Top-down Approaches for This Report Figure 109. Data Triangulation Figure 110. Key Executives Interviewed

GlaxoSmithKline Sanofi Pasteur, Ltd. Merck